Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2016

Mar 3, 2016

31971_dirs_2016-03-03_e52489c5-c873-4174-92cb-cfc863dca73e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2016-03-01

Reporting Person: Snyder Mark D (EVP Mfg. Ops & Business System)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-01 Common Stock M 300 Acquired 14158 Direct
2016-03-01 Common Stock F 98 $39.87 Disposed 14060 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-03-01 Rsus (restricted Stock Units) $0 M 300 Disposed 2025-02-27 Common Stock (300) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.